In this PhD studentship, Professor Peter Zammit and his student, Louise Moyle, explored the role that muscle stem cells have in facioscapulohumeral muscular dystrophy (FSH). They delivered the protein thought to cause FSH (DUX4) into muscle stem cells. DUX4 altered the activity of many genes involved in the way that cells communicate. From this, the researchers identified a protein that appears to contribute to FSH pathology. They then tested clinically-approved drugs against this protein in cell models of FSH to begin to develop a potential therapy.
In this PhD studentship, Professor Peter Zammit and his student, Louise Moyle, explored the role that muscle stem cells have in facioscapulohumeral muscular dystrophy (FSH). They delivered the protein thought to cause FSH (DUX4) into muscle stem cells. DUX4 altered the activity of many genes involved in the way that cells communicate. From this, the researchers identified a protein that appears to contribute to FSH pathology. They then tested clinically-approved drugs against this protein in cell models of FSH to begin to develop a potential therapy.
In this PhD studentship, Professor Peter Zammit and his student, Louise Moyle, explored the role that muscle stem cells have in facioscapulohumeral muscular dystrophy (FSH). They delivered the protein thought to cause FSH (DUX4) into muscle stem cells. DUX4 altered the activity of many genes involved in the way that cells communicate. From this, the researchers identified a protein that appears to contribute to FSH pathology. They then tested clinically-approved drugs against this protein in cell models of FSH to begin to develop a potential therapy.